Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA ...

According to NSE bulk deal data, Vanguard Emerging Markets Stock Index Fund A Series of VIEIF purchased 0.83 million shares ...

Lexicon Pharmaceuticals granted Novo Nordisk exclusive rights to develop LX9851, an oral obesity drug, with potential ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

Discover an intriguing stock idea with Mankind Pharma showing signs of a rebound and potential upside in price action.

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

Corvus Pharmaceuticals has faced volatility due to mixed clinical data and given the current valuation and market ...

Amneal Pharmaceuticals, Inc. offers strong growth prospects with undervalued stock, rising revenues, reduced debt, and key ...

Milestone Pharmaceuticals Inc.’s MIST share price has dipped by 61.33%, which has investors questioning if this is right time to buy.

With a diverse portfolio of eight FDA-approved medications targeting neurological conditions, Supernus Pharmaceuticals ...

Armata Pharmaceuticals, Inc.’s ARMP share price has surged by 10.02%, which has investors questioning if this is right time to sell.

We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a ...